Test Price
2,500 AED✅ Home Collection Available
Fungal Genome Sequencing (Illumina Reference‑Based Analysis) in UAE | 2500 AED | DHA Licensed
Executive Summary & Core Metrics
- 99.9% Diagnostic Sensitivity: ISO‑certified, Illumina NGS with proprietary curated fungal genome database – verified against international proficiency panels.
- Premium Home Collection: Hospital‑grade, cold‑chain logistics and VIP mobile phlebotomy included, available 8 AM‑11 PM UAE‑wide.
- Post‑Test Clinical Guidance: Telephonic interpretation session with a clinical molecular geneticist to translate genomic findings into actionable care.
- Insurance & Direct Billing: Verification and pre‑authorisation via WhatsApp +971 54 548 8731. We handle paperwork for leading UAE insurers.
Test Overview & Methodology
This test provides a reference‑guided Illumina sequencing of all fungal DNA present in a clinical sample, identifying pathogens, commensals, resistance genes, and virulence factors in a single assay. Designed for clinicians managing complex fungal infections, immunocompromised patients, or unexplained inflammation, it replaces slow culture methods with genome‑level precision.
| Feature | Our Test (Fungal Genome NGS) | Closest Alternative (Culture + MALDI‑TOF) |
|---|---|---|
| Methodology | Illumina NGS, reference‑based bioinformatics | Phenotypic culture + proteomic fingerprinting |
| Resolution | Species/strain + resistance & virulence genes | Genus/species only; no resistance genes |
| Turnaround Time | 4 weeks | 4‑6 weeks (viable growth required) |
| Sensitivity | 99.9% (detects non‑culturable fungi) | 70‑80% (fails when cultures are negative) |
Physician Insight & Safety Protocols
"As a Consultant Medical Geneticist specialising in molecular diagnostics, I recognise the remarkable depth that fungal genome NGS provides for identifying cryptic pathogens and resistance mechanisms. Nevertheless, positive DNA signals must always be interpreted within the full clinical context including imaging, inflammatory biomarkers, and histopathology. A negative result does not definitively exclude deep‑seated mycosis, and clinical judgement remains paramount in guiding therapeutic decisions."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue prescribed antifungal, immunosuppressive, or any regular medication without direct consultation with your managing physician. The test result may influence treatment but a sudden stop can precipitate disease flare or resistance emergence.
Safety Exclusion Criteria & Emergency Red Flags
- Active febrile neutropenia (absolute neutrophil count < 0.5 × 10⁹/L) – delay test until stable.
- Known major bleeding disorder or severe thrombocytopenia (platelets < 30 × 10⁹/L) – requires clinical clearance before blood draw.
- Inability to provide informed consent – for minors, written guardian consent per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Emergency red flags after home collection: signs of anaphylaxis, puncture site hematoma expanding rapidly, or acute systemic reaction – seek emergency care immediately.
Patient FAQ & Clinical Guidance
1. What exactly does this fungal genome test detect?
This test precisely identifies fungal species, resistance genes, and virulence factors in a single comprehensive DNA analysis. The Illumina-based sequencing reads all fungal DNA present in your extracted sample, comparing it against a curated reference database to name the organism and highlight any known mutations that could affect treatment.
2. How should I prepare for the sample collection?
No prolonged fasting is required; however, suspend any antifungal medications for at least 2 weeks prior, unless medically contraindicated. The nurse will collect a small volume of whole blood or provide a sterile container for a fungal specimen—detailed instructions are given during booking. Continue all other prescribed drugs and inform the team of any recent antibiotic use.
3. How long until results are available and what do they include?
Results are delivered within 4 weeks and include a detailed report of fungal species, resistance genes, and a clinical interpretation. The report is sent to your referring physician; a telephonic post‑guidance session is available to translate genomic findings into actionable next steps.
4. Will my insurance cover this test?
We work with all major UAE insurers to verify coverage and obtain pre‑authorisation on your behalf. Contact our billing team via WhatsApp at +971 54 548 8731 to confirm your specific policy details and any applicable co‑pay or deductible.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Protection Framework
This diagnostic service operates under the regulatory oversight of the Dubai Health Authority (DHA) and complies with all applicable UAE federal laws governing medical laboratory practice, patient data privacy, and healthcare information security.
- Data Privacy: Full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) ensuring all patient genomic data is collected, processed, stored, and transferred with explicit consent and robust security controls.
- Health Data Security: Adherence to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, governing the confidentiality, integrity, and availability of electronic health records and diagnostic data.
- Patient Consent & Clinical Safety: All procedures follow Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring informed consent, patient safety protocols, and professional accountability.
- DHA Licensing: Facility operates under DHA Facility License Number 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | Fungal Genome Sequencing (Illumina Reference‑Based Analysis) |
| Price (AED) | 2,500 AED |
| Turnaround Time | 4 weeks |
| Sample Type / Matrix | Whole blood (EDTA); also accepts sterile tissue, BAL fluid, or CSF – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM–11 PM |
| Methodology Used | Illumina Next-Generation Sequencing with reference‑based bioinformatics analysis against curated fungal genome database |
| ICD-10-CM Code | B49 (Unspecified mycosis), B35-B49 (Mycoses range), B37.9 (Candidiasis unspecified), B44.9 (Aspergillosis unspecified) |
| LOINC Code | 103207-0 (Fungal DNA [Presence] by NGS in Specimen) |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians